Maurizi Enrici R, Busi E, Guglielmi C, Martelli M, Pizzi C, Tombolini V, Biagini C
Radiol Med. 1987 Jul-Aug;74(1-2):103-8.
The staging, therapy and course of 91 patients with extranodal NHL of the head and neck treated between 1970 and 1985, were analyzed. The sites involved were: Waldeyer's ring 71 patients, tonsil 59, nasopharynx 12 and extralymphatic sites 20 patients (larynx 6, paranasal sinus 5, orbit 5, oral cavity 3, salivary gland 1). Sixty-three patients had unfavourable histology with 22 patients in stage I; 33 in II; 21 in III; 15 in IV. Chemotherapy plus radiotherapy was used in 43 patients and 34 obtained Complete Remission (CR). Chemotherapy alone was used in 30 patients and in 11 CR was achieved, radiotherapy alone in 18 patients and 11 obtained CR. The actuarial survival rate was 55% and recurrence-free survival, evaluated only in those patients who achieved complete remission, was 80%. Results, as survival and freedom from recurrence, are analyzed in relation to main prognostic factors and therapy, and patterns of recurrence are reported. The present study confirmed the view that radiotherapy combined with chemotherapy represents the best treatment for NHL of the head and neck.
对1970年至1985年间接受治疗的91例头颈部结外非霍奇金淋巴瘤(NHL)患者的分期、治疗及病程进行了分析。受累部位包括:韦氏环71例患者,扁桃体59例,鼻咽12例,结外部位20例患者(喉6例,鼻窦5例,眼眶5例,口腔3例,唾液腺1例)。63例患者组织学类型不佳,其中I期22例;II期33例;III期21例;IV期15例。43例患者采用化疗加放疗,34例获得完全缓解(CR)。30例患者单纯采用化疗,11例获得CR,18例患者单纯采用放疗,11例获得CR。精算生存率为55%,仅对获得完全缓解的患者评估的无复发生存率为80%。分析了生存和无复发结果与主要预后因素及治疗的关系,并报告了复发模式。本研究证实了放疗联合化疗是头颈部NHL最佳治疗方法的观点。